GFL Environmental Inc. Subordinate voting shares no par value vs Liquidia Corporation Common Stock — how do they compare? GFL Environmental Inc. Subordinate voting shares no par value trades at $43.02 (market cap $18.64B), while Liquidia Corporation Common Stock trades at $33.66 (market cap $2.40B). The key difference: GFL Environmental Inc. Subordinate voting shares no par value is far larger — about 7.8× Liquidia Corporation Common Stock's market cap, and GFL Environmental Inc. Subordinate voting shares no par value pays a 0.16% dividend while Liquidia Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold GFL Environmental Inc. Subordinate voting shares no par value for 6 Days and Liquidia Corporation Common Stock for 0 Days on average.
| GFL | LQDA | |
|---|---|---|
Market Cap | $18.64B | $2.40B |
Volume | 2,514,524 | 2,857,547 |
Sector | Industrials | Health |
52-Week High | $46.51 | $91.03 |
52-Week Low | $33.54 | $22.02 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $25.61B | $2.30B |
Dividend Yield | 0.16% | — |
Signals from Pluang's Aura AI — not financial advice
GFL trades at $42.75, up 0.87% today, with a bullish technical signal from moving averages. Recent Q2 2026 earnings missed estimates, but the company raised full-year 2026 guidance. Revenue is projected to grow to $7.0B in 2026, though net income is expected to turn negative. The company recently acquired SECURE Waste Infrastructure and announced a quarterly dividend, signaling financial activity.
Outlook is mixed: strong analyst buy consensus (77.8%) and positive news flow support upside, but negative profit margins and high valuation ratios pose risks. The stock's performance hinges on execution of growth initiatives and margin improvement in a competitive industrial sector.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
GFL Environmental provides environmental services across Canada and the United States. Its operations include solid waste management and other waste and environmental solutions.
Read more on GFL →Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →